• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺转移系数与哮喘-COPD 重叠症患者加重风险的相关性:一项观察性队列研究。

The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap: an observational cohort study.

机构信息

Department of Respiratory Medicine, National Hospital Organization Fukuoka National Hospital, 4-39-1 Yakatabaru, Minami-ku, Fukuoka, 811-1394, Japan.

出版信息

BMC Pulm Med. 2022 Jan 12;22(1):22. doi: 10.1186/s12890-021-01815-w.

DOI:10.1186/s12890-021-01815-w
PMID:35016668
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8753934/
Abstract

BACKGROUND

Asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) patients experience exacerbations more frequently than those with asthma or COPD alone. Since low diffusing capacity of the lung for carbon monoxide (D) is known as a strong risk factor for severe exacerbation in COPD, D or a transfer coefficient of the lung for carbon monoxide (K) is speculated to also be associated with the risk of exacerbations in ACO.

METHODS

This study was conducted as an observational cohort survey at the National Hospital Organization Fukuoka National Hospital. D and K were measured in 94 patients aged ≥ 40 years with a confirmed diagnosis of ACO. Multivariable-adjusted hazard ratios (HRs) for the exacerbation-free rate over one year were estimated and compared across the levels of D and K.

RESULTS

Within one year, 33.3% of the cohort experienced exacerbations. After adjustment for potential confounders, low K (< 80% per predicted) was positively associated with the incidence of exacerbation (multivariable-adjusted HR = 3.71 (95% confidence interval 1.32-10.4)). The association between low D (< 80% per predicted) and exacerbations showed similar trends, although it failed to reach statistical significance (multivariable-adjusted HR = 1.31 (95% confidence interval 0.55-3.11)).

CONCLUSIONS

Low K was a significant risk factor for exacerbations among patients with ACO. Clinicians should be aware that ACO patients with impaired K are at increased risk of exacerbations and that careful management in such a population is mandatory.

摘要

背景

哮喘-慢性阻塞性肺疾病(COPD)重叠(ACO)患者比单独患有哮喘或 COPD 的患者更频繁地经历恶化。由于一氧化碳的肺弥散量低(D)已知是 COPD 严重恶化的一个强烈危险因素,因此推测 D 或一氧化碳的肺转移系数(K)也与 ACO 恶化的风险相关。

方法

本研究是在国立医院组织福冈国立医院进行的一项观察性队列调查。在年龄≥40 岁且确诊为 ACO 的 94 名患者中测量了 D 和 K。估计了一年无恶化率的多变量调整后的风险比(HR),并比较了 D 和 K 水平之间的差异。

结果

在一年内,队列中有 33.3%的患者经历了恶化。在调整了潜在的混杂因素后,低 K(<80%预计值)与恶化的发生呈正相关(多变量调整后的 HR=3.71(95%置信区间 1.32-10.4))。低 D(<80%预计值)与恶化之间的关联也呈现出相似的趋势,但未达到统计学意义(多变量调整后的 HR=1.31(95%置信区间 0.55-3.11))。

结论

低 K 是 ACO 患者恶化的一个显著危险因素。临床医生应该意识到,K 受损的 ACO 患者恶化的风险增加,因此在这种人群中必须进行谨慎的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/a26472b95137/12890_2021_1815_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/527fa537e98f/12890_2021_1815_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/6e941cc6a81d/12890_2021_1815_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/a8931b99d2ea/12890_2021_1815_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/a26472b95137/12890_2021_1815_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/527fa537e98f/12890_2021_1815_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/6e941cc6a81d/12890_2021_1815_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/a8931b99d2ea/12890_2021_1815_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0b9/8753934/a26472b95137/12890_2021_1815_Fig4_HTML.jpg

相似文献

1
The association between transfer coefficient of the lung and the risk of exacerbation in asthma-COPD overlap: an observational cohort study.肺转移系数与哮喘-COPD 重叠症患者加重风险的相关性:一项观察性队列研究。
BMC Pulm Med. 2022 Jan 12;22(1):22. doi: 10.1186/s12890-021-01815-w.
2
Transfer coefficients better reflect emphysematous changes than carbon monoxide diffusing capacity in obstructive lung diseases.在阻塞性肺部疾病中,转移系数比一氧化碳弥散量更能反映肺气肿的变化。
J Appl Physiol (1985). 2018 Jul 1;125(1):183-189. doi: 10.1152/japplphysiol.01062.2017. Epub 2018 Apr 12.
3
Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.调整一氧化碳弥散量(DLCO)和一氧化碳转移系数(KCO)以适应肺泡容积的重要性。
Respir Med. 2000 Jan;94(1):28-37. doi: 10.1053/rmed.1999.0740.
4
Heterogeneity of asthma and COPD overlap.哮喘与慢性阻塞性肺疾病重叠的异质性。
Int J Chron Obstruct Pulmon Dis. 2018 Apr 17;13:1251-1260. doi: 10.2147/COPD.S152916. eCollection 2018.
5
Diffusing Capacity of Carbon Monoxide in Assessment of COPD.一氧化碳弥散量在 COPD 评估中的应用。
Chest. 2019 Dec;156(6):1111-1119. doi: 10.1016/j.chest.2019.06.035. Epub 2019 Jul 25.
6
Prognostic marker for severe acute exacerbation of chronic obstructive pulmonary disease: analysis of diffusing capacity of the lung for carbon monoxide (D) and forced expiratory volume in one second (FEV).慢性阻塞性肺疾病急性加重严重程度的预后标志物:一氧化碳弥散量(D)和一秒用力呼气容积(FEV)分析。
BMC Pulm Med. 2021 May 6;21(1):152. doi: 10.1186/s12890-021-01519-1.
7
Metformin use and respiratory outcomes in asthma-COPD overlap.二甲双胍在哮喘-COPD 重叠患者中的应用与呼吸系统结局。
Respir Res. 2021 Feb 26;22(1):70. doi: 10.1186/s12931-021-01658-3.
8
Asthma Is a Risk Factor for Respiratory Exacerbations Without Increased Rate of Lung Function Decline: Five-Year Follow-up in Adult Smokers From the COPDGene Study.哮喘是导致成年吸烟者 COPDGene 研究中呼吸恶化而肺功能下降率无增加的一个风险因素:为期五年的随访。
Chest. 2018 Feb;153(2):368-377. doi: 10.1016/j.chest.2017.11.038. Epub 2017 Dec 15.
9
Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.气道阻塞患者中哮喘-COPD 重叠、哮喘和慢性阻塞性肺疾病表型的鉴定:对治疗方法的影响。
Respiration. 2020;99(1):35-42. doi: 10.1159/000503328. Epub 2019 Nov 6.
10
Functional Predictors Discriminating Asthma-COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD).用于区分哮喘-慢性阻塞性肺疾病重叠(ACO)与慢性阻塞性肺疾病(COPD)的功能预测因子。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 21;17:2723-2743. doi: 10.2147/COPD.S382761. eCollection 2022.

本文引用的文献

1
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease.糠酸氟替卡松/乌美溴铵/维兰特罗三联疗法治疗慢性阻塞性肺疾病患者的真实临床和功能效果。
Respiration. 2021;100(2):127-134. doi: 10.1159/000512064. Epub 2020 Dec 10.
2
Diffusing Capacity of Carbon Monoxide in Assessment of COPD.一氧化碳弥散量在 COPD 评估中的应用。
Chest. 2019 Dec;156(6):1111-1119. doi: 10.1016/j.chest.2019.06.035. Epub 2019 Jul 25.
3
Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.
FEV1:FVC 阈值对 COPD 相关住院和死亡的鉴别准确性。
JAMA. 2019 Jun 25;321(24):2438-2447. doi: 10.1001/jama.2019.7233.
4
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD.支气管扩张对 COPD 外周气道炎症生物标志物的影响。
Pharmacol Res. 2018 Jul;133:160-169. doi: 10.1016/j.phrs.2018.05.010. Epub 2018 May 23.
5
Transfer coefficients better reflect emphysematous changes than carbon monoxide diffusing capacity in obstructive lung diseases.在阻塞性肺部疾病中,转移系数比一氧化碳弥散量更能反映肺气肿的变化。
J Appl Physiol (1985). 2018 Jul 1;125(1):183-189. doi: 10.1152/japplphysiol.01062.2017. Epub 2018 Apr 12.
6
Defining the "Frequent Exacerbator" Phenotype in COPD: A Hypothesis-Free Approach.COPD 中“频繁加重者”表型的定义:一种无假设方法。
Chest. 2018 May;153(5):1106-1115. doi: 10.1016/j.chest.2017.10.009. Epub 2017 Oct 17.
7
Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians.官方 ERS 技术标准:高加索人群一氧化碳传递因子的全球肺功能倡议参考值。
Eur Respir J. 2017 Sep 11;50(3). doi: 10.1183/13993003.00010-2017. Print 2017 Sep.
8
Influence of resting lung diffusion on exercise capacity in patients with COPD.静息肺弥散对 COPD 患者运动能力的影响。
BMC Pulm Med. 2017 Aug 25;17(1):117. doi: 10.1186/s12890-017-0454-y.
9
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
10
Prediction models for exacerbations in patients with COPD.慢性阻塞性肺疾病患者急性加重的预测模型
Eur Respir Rev. 2017 Jan 17;26(143). doi: 10.1183/16000617.0061-2016. Print 2017 Jan.